Dabigatran – an exemplar case history demonstrating the need for comprehensive models to optimise the use of new drugs

by Brian eGodman, Brian eGodman, Rickard eMalmstrom, Eduardo eDiogene, Sisira eJayathissa, Stuart eMcTaggart, Thomas eCars, Thomas eCars, Christoph eBaumgärtel, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Kristina eGaruoliene, Iñaki eGutiérrez-Ibarluzea, Krystyna eHviding, Harald eHerholz, Roberta eJoppi, Marija eKalaba, Ott eLaius, Kamila eMalinowska, Kamila eMalinowska, Hanne B Pedersen, Vanda eMarkovic-Pekovic, Vanda eMarkovic-Pekovic, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Magdelena eWladysiuk, Menno eVan Woerkom, Corinne eZara, Lars L Gustafsson
Published 2014-06-01